\
&
Contact us
\
&
Contact us
Published on | 55 minutes ago
ProgrammesNCP Flanders has extended the duration of its short satisfaction survey to gather valuable feedback and suggestions on the NCP services.
The survey is fully anonymous and is open until 9 October 2026.
It is organised into three sections: NCP Flanders assistance, info sessions, and NCP Flanders website & LinkedIn. If you are not familiar with one of these sections, the survey will automatically guide you to the next section.
The NCP Flanders team would greatly appreciate it if you could take a few minutes to fill in the survey and provide your opinion via this link.
If you would like to get in touch with NCP Flanders, please email info@ncpflanders.be
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Agro-Food, Environment Missions
The FOREST Partnership has opened a call for experts read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
